Glaucoma, eye surface health, and tear proteins
Part of Eyes & vision clinical trials.
This study looks at how glaucoma and its treatments affect the surface of the eye and proteins in tears. It may help find better ways to manage eye health in people with glaucoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You either have no glaucoma, or you have a specific type of glaucoma (angle-closure, open-angle, or high eye pressure) that fits one of the study groups.
- You have not had severe eye injuries, chemical burns, or certain eye surgeries.
- You do not have other eye surface problems that are not related to glaucoma or dry eye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long-term use of glaucoma eye drops may affect the surface of the eye (the clear front layer). It aims to find out if these drops cause dry-eye or other surface problems, which can help doctors better manage treatment.
This study measures inflammation markers on the eye surface in people with primary open-angle glaucoma or ocular hypertension who use certain glaucoma drops. The results may help doctors understand how these drops affect the eye and inflammation.
This study tracks changes in blood flow, structure, and vision over time in people with glaucoma or high eye pressure. It aims to understand how these conditions progress, which could help improve future treatment.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
This observational study follows patients with limbal stem cell deficiency (a condition affecting cells at the edge of the cornea that help maintain healthy eye surface) to understand how their vision changes over time. Researchers will track your eye health without giving you new treatment.
This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.